<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">67</article-id>
<title-group><article-title>Womenâ€™s experience with post placental intrauterine contraceptive device use in a tertiary care Centre in Pakistan</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Safdar</surname><given-names>Zahra</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Sabir</surname><given-names>Sumaira Fatima</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Zaib</surname><given-names>Sumaira</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Abid</surname><given-names>Saleeha</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<aff id="aff1"><label>1</label>Senior Registrar Obstetrics and Gynecology Lahore General Hospital, Lahore, Pakistan</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><year>2021</year></pub-date>
<volume>2</volume>
<issue>1</issue>
<fpage>01</fpage>
<lpage>04</lpage>
<history>
<date date-type="received"><day>01</day><month>01</month><year>2021</year></date>
<date date-type="accepted"><day>16</day><month>01</month><year>2021</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/67/women-s-experience-with-post-placental-intrauterine-contraceptive-device-use-in-a-tertiary-care"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/67/download"/>
<abstract><p>Background: Insertion of post placental intrauterine contraceptive device (PPIUCD) has been recommended by the WHO, as one of the safe and effective methods of temporary contraception. In the immediate post delivery period, women are highly driven and in need of an effective method for contraception so that the child rearing can be easy without unintended pregnancy. rnObjective: To assess the outcome of women accepting PPIUCD in terms of insertion, complications and discontinuation rate at 6 weeks and 6 months. rnSubjects &amp; MethodsrnStudy Design: Retrospective cross sectional study rnStudy Setting: Department of Obstetrics &amp; Gynecology, Lahore General Hospital, Lahore, Study Duration: May, 2015 till August, 2019. rnData collection and analysis: After approval from hospital ethical committee, Data was retrieved from Maternal and Neonatal Child Health (MNCH) program. Record of clinical visit and telephonic survey for miscellaneous complaints at 6weeks and 6 months were evaluated from the medical records department and relevant data were extracted. The data were analysed using SPSS version 21 and the results expressed in descriptive statistics in frequency and percentages.rnResults: Total live births during study period were 43065. PPIUCD was inserted in 5275 women (12.24%). Only 13% presented for clinical follow up, 87% had telephonic conversation. Of these, 33% were advised clinical visit. 83% reported no complaints. Reassurance was needed in 11%, threads trimmed in 2%. Problems reported were displaced IUCD 3.3%, spontaneous expulsion 24%, vaginal infections 4.7%, missing strings 3%, cramping 25%, dyspareunia, 6%, spotting 52% vaginal discharge 16%. Ultrasound was advised to 3%, symptomatic treatment to 14%, antibiotics and IUCD removal in 0.7%. IUCD discontinued by 6.7% women for various reasons e. g family pressure 0.3%, wanting a further child 0.7% and 14% opted for another method of family planning. IUCD removed and reinserted in 4.9%.rnConclusion: PPIUCD has a low turnover rate of follow-up but has high compliance with devices and low complication rate and complications can be reduced by improving patient selection and clinical follow up. It provides an excellent window of opportunity for providing effective long term contraception to the patients who need it most.</p></abstract>
<kwd-group kwd-group-type="author"><kwd>Contraception</kwd><kwd>Post placental</kwd><kwd>IUCD</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Dimaras H, Corson TW. Retinoblastoma, the visible CNS tumor: a review. J Neurosci Res. 2019; 97(1):29-44. https:// doi.org/10.1002/jnr.24213</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Sultana R, Hafeez M, nd Badar N. Reasons of Refusal to Postpartum Intrauterine Contraceptive Device. JSOGP. 2017; 7(4):177-181.</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Forty J, Rakgoasi SD, Keetile M. Patterns and determinants of modern contraceptive use and intention to usecontraceptives among Malawian women of reproductive ages (15-49 years). Contracept Reprod Med. 2021; 6(1):21.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Dixit A, et al. Male-female concordance in reported involvement of women in contraceptive decision-making and its association with modern contraceptive use among couples in rural Maharashtra, India. Reprod Health. 2021; 18(1):139.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Kumar S, et al. Women’s experience with postpartum intrauterine contraceptive device use in India. Reprod Health. 2014; 11(1):32.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Lm L, Bernholc A, Hubacher D, Stuart G, Haam VV, Immediate postpartum insertion of intrauterine device for contraception ( Review). Cochrane Database Syst Rev. 2015; 26(6):CD003036.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Hooda R, Mann S, Immediate Postpartum Intrauterine Contraceptive Device Insertions in Caesarean and Vaginal Deliveries: A Comparative Study of Follow-Up Outcomes. Int J Reprod Med. 2016; 2016:7695847.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Wildemeersch D, et al. Intrauterine device quo vadis? Why intrauterine device use should be revisited particularly in nulliparous women? J Contracept. 2015; 6:1-12.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Mohammed SJ, Kelbore WG, et al. Determinants of Postpartum IUCD Utilization Among Mothers Who Gave Birth in Gamo Zone Public Health Facilities, Southern Ethiopia: A Case-Control Study. J Contracept. 2020; 11:125-133.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>WHO Guidelines Approved by the Guidelines Review Committee, in Selected Practice Recommendations for Contraceptive Use. 2016, World Health Organization</mixed-citation></ref>
</ref-list></back>
</article>